Correction: Aloe-emodin inhibits HER-2 expression through the downregulation of Y-box binding protein-1 in HER-2-overexpressing human breast cancer cells

Oncotarget. 2019 Oct 1;10(55):5727-5729. doi: 10.18632/oncotarget.27230.

Jui-Wen Ma¹, Chao-Ming Hung^{2

3}, Ying-Chao Lin^{4

5

6}, Chi-Tang Ho⁷, Jung-Yie Kao¹, Tzong-Der Way^{8

9}

¹ Institute of Biochemistry, College of Life Science, National Chung Hsing University, Taichung, Taiwan.
² Department of General Surgery, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan.
³ School of Medicine, I-Shou University, Kaohsiung, Taiwan.
⁴ Division of Neurosurgery, Buddhist Tzu Chi General Hospital, Taichung Branch, Taiwan.
⁵ School of Medicine, Tzu Chi University, Hualien, Taiwan.
⁶ Department of Medical Imaging and Radiological Science, Central Taiwan University of Science and Technology, Taichung, Taiwan.
⁷ Department of Food Science, Rutgers University, New Brunswick, New Jersey, USA.
⁸ Department of Biological Science and Technology, College of Biopharmaceutical and Food Sciences, China Medical University, Taichung, Taiwan.
⁹ Department of Health and Nutrition Biotechnology, College of Health Science, Asia University, Taichung, Taiwan.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.10410.].